Cargando…
Western blot using Trypanosoma cruzi chimeric recombinant proteins for the serodiagnosis of chronic Chagas disease: A proof-of-concept study
BACKGROUND: Chagas disease (CD) is caused by Trypanosoma cruzi. The chronic phase of CD is characterized by the presence of IgG anti-T. cruzi antibodies; and diagnosis is performed by serological methods. Because there is no reliable test that can be used as a reference test, WHO recommends the para...
Autores principales: | Daltro, Ramona Tavares, Santos, Emily Ferreira, Silva, Ângelo Antônio Oliveira, Maron Freitas, Natália Erdens, Leony, Leonardo Maia, Vasconcelos, Larissa Carvalho Medrado, Luquetti, Alejandro Ostermayer, Celedon, Paola Alejandra Fiorani, Zanchin, Nilson Ivo Tonin, Regis-Silva, Carlos Gustavo, Santos, Fred Luciano Neves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731424/ https://www.ncbi.nlm.nih.gov/pubmed/36441769 http://dx.doi.org/10.1371/journal.pntd.0010944 |
Ejemplares similares
-
Stability Assessment of Four Chimeric Proteins for Human Chagas Disease Immunodiagnosis
por: Celedon, Paola Alejandra Fiorani, et al.
Publicado: (2021) -
Performance of Chimeric Trypanosoma cruzi Antigens in Serological Screening for Chagas Disease in Blood Banks
por: dos Santos, Emily Ferreira, et al.
Publicado: (2022) -
Double-antigen sandwich ELISA based on chimeric antigens for detection of antibodies to Trypanosoma cruzi in human sera
por: Freitas, Natália Erdens Maron, et al.
Publicado: (2022) -
Cross-Reactivity Using Chimeric Trypanosoma cruzi Antigens: Diagnostic Performance in Settings Where Chagas Disease and American Cutaneous or Visceral Leishmaniasis Are Coendemic
por: Daltro, Ramona Tavares, et al.
Publicado: (2019) -
Detection of anti-Trypanosoma cruzi antibodies by chimeric antigens in chronic Chagas disease-individuals from endemic South American countries
por: Del-Rei, Rodrigo Pimenta, et al.
Publicado: (2019)